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1. Introduction 
Glycoproteins have a unique position in the pathogenesis of human diseases. Most of the 
commonly employed protein biomarkers are glycoproteins. Examples include CA19-9 
(carbohydrate antigen 19-9) to follow-up patients with pancreatic cancer, CEA 
(carcinoembryonic antigen) for multiple solid tumors and CA125 (carbohydrate antigen 125) 
used in the diagnosis, follow-up and therapy of patients with ovarian cancer. Most of these 
glycoproteins are large molecules. However, there is a family of smaller, secreted 
glycoproteins (called lipocalins) that are important in the maintenance of health and in 
combating diseases effectively. A prototype of this family is a small, secreted glycoprotein 
called Neutrophil gelatinase associated lipocalin or NGAL. In recent years, NGAL has 
emerged as a novel biomarker in several benign and malignant diseases. Further, studies in 
cultured cells and in murine models have revealed a pivotal role for this molecule in several 
physiological processes and pathological conditions. In this Chapter, we review the biology 
of lipocalins, focusing specifically on NGAL and its role in human health and disease.   
2. The lipocalin family 
Lipocalins are a family of small (160-180 amino acids long) secreted proteins that mediate 
(among other functions) a common functional role- i.e., transportation of small hydrophobic 
ligands. Most protein families are classified on the basis of similarity in amino acid 
sequences, domain architecture and three-dimensional protein structure. The lipocalins 
however are a unique exception in that the percentage of sequence identity among different 
members of the lipocalin family is sometimes even lower than the minimum (20%) identity 
required to call it a reliable alignment (Flower et al., 2000; Flower, 1996; Flower, 1995; 
Flower, 1994). Despite this lack of a sequence similarity, the lipocalins share three short 
stretches of amino acid sequences (or motifs) that are part of the structural conservation 
among different lipocalin sequences. These motifs, which are aptly termed as "structurally 
conserved regions or SCRs" are used to classify this large family into two main sub-families- 
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the "kernel" and the "outlier" lipocalins (Table 1). The kernel lipocalins contain all three 
motifs while the outlier lipocalins contain only one or two of these (but not all three) SCRs.  
 
Abbreviation Protein name 
Kernel Lipocalins  
Alpha 1M  Αlpha 1-microglobulin 
ApoD Apolipoprotein D 
A2U ǂ2micro-Globulin 
BBP Bilin binding protein 
Blg ǃ1-Lactoglobulin 
C8Ǆ C8Ǆ 
CPP Choroid plexus protein 
CRABP2 Cellular Retinoic acid binding protein 
ACC ǂ-Crustacyanin 
MUP Major Urinary Protein 
NGAL Neutrophil gelatinase associated Lipocalin 
PGDS Prostaglandin D synthase 
PP14 Pregnancy protein 14 
PURP Purpurin 
 Lazarillo 
Outlier Lipocalins  
AAAG Αlpha 1-Acid glycoprotein 
 Aphrodisin 
OBP Odorant binding protein 
 Probasin 
VEGP von Ebner’s-gland protein 
Table 1. List of known Kernel and Outlier Lipocalin proteins 
The secondary and tertiary structure of the lipocalin family members is very similar and is 
characterized by the presence of a "lipocalin fold"- a symmetrical structure comprised 
almost entirely of ǃ-pleated sheets closed at the two ends by two ǂ helices (Figure 1). There 
are eight antiparallel ǃ sheets linked to each other by seven short loops. The N-terminal 
region of the protein forms the ligand binding cavity which is closed by a conserved 310 
helix. The cup-shaped cavity of the lipocalins enclosed within the ǃ-pleated sheets is well 
adapted for binding to a wide array of hydrophobic ligands- for instance, while retinol 
binding protein (RBP) binds primarily to its endogenous ligand retinol, it can also bind to 
several other hydrophobic ligands including ǃ-ionone, ǃ-carotene, cholesterol, terpenoids 
and long chain esters of retinol and retinoic acid.  
Many lipocalins have also been shown to bind to specific receptors including RBP, alpha1-
microglobulin, major urinary protein (MUP) and Odorant-binding protein (OBP). A third 
property of lipocalins is their tendency to form complexes with soluble macromolecules. 
Some of the well-known protein-protein complexes involving the lipocalin family members 
include the complex of RBP with transthyretin, NGAL with human neutrophil gelatinase, 
C8Ǆ with C8ǂ as part of the membrane attack complex (MAC) and ǂ1-microglobulin (A1M) 
with immunoglobulin A (IgA). These associations may either serve to transport proteins 
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(RBP), stabilize the interactor (NGAL), protect normal cells from damage (C8Ǆ) or alter the 
biological activity of the interacting protein (A1M).  
 
 
Fig. 1. Schematic representation of the lipocalin fold. The characteristic feature of lipocalins 
is the “lipocalin fold” which comprises of an N-terminal 3-10 helix followed by eight beta 
sheets (A-I) arranged in an antiparallel orientation. The eighth beta sheet is connected to an 
alpha helix (denoted as ǂ1), which is in turn connected to a C-terminal beta sheet. The beta 
sheets are connected by loops (L1-L7). Loops L1,L3,L5 and L7 form the open end of the 
molecule (i.e. the opening to the ligand binding site of NGAL). The portion of the lipocalin 
fold that are structurally conserved between different lipocalins is indicated by the blue 
boxed regions while the region that shows significant conservation in amino acid sequence 
is indicated by the black boxed region.  
Functionally, the lipocalins are generally well known as transport proteins that exist in the 
extracellular space. The prototypical lipocalin involved in transport of cargo in the body is 
RBP which binds to and transports retinol (Vitamin A) from the liver to various organs. 
Binding to RBP not only protects retinol from being excreted by the kidneys but also from 
being oxidized within the body. Further, it also permits the transport of a relatively 
insoluble retinol in the form of a soluble complex to the tissues to mediate its effects. Other 
functions attributed to lipocalins including regulation of cell ageing, survival and 
differentiation (probasin and purpurin), modulation of immune response (NGAL, AGP, 
PP14 and AIM), prostaglandin synthesis (glutathione-independent PGD2 synthase), 
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coloration (insecticyanin, BBP and crusticyanin), smell (OBP), taste (VEGP) and as sex 
hormones or pheromones (MUP and Aphrodisin) (Flower et al., 2000; Flower, 1996; Flower, 
1995; Flower, 1994). We will examine the role of a member of the lipocalin family (NGAL) 
that has been extensively studied particularly as a potential marker for diagnosis and 
prognosis in several human diseases. We will investigate its biology, functions and clinical 
applications both in benign and malignant diseases. 
3. Neutrophil gelatinase associated lipocalin (NGAL)-genomic organization 
and protein structure 
Neutrophil gelatinase associated lipocalin (NGAL) also known as migration stimulating 
factor inhibitor (MSFI), human neutrophil lipocalin (HNL), alpha-1 microglobulin related 
protein, siderocalin or uterocalin is a 198 amino acid glycoprotein encoded by a gene located 
on the chromosome locus 3p11. It was first isolated from mouse kidney cells infected with a 
simian virus (SV-40) (Hraba-Renevey et al., 1989). Triebel and colleagues identified a novel 
association between NGAL and the gelatinolytic enzyme MMP-9 (matrix metalloproteinase 
9 or gelatinase B) known to degrade several components of the basement membrane 
including type I gelatin and collagen types I, IV, V and XI (Triebel et al., 1992). Human 
NGAL protein (or LCN2) is represented in upper case, while the murine and rat 
homologues are usually represented in lower case (Ngal or Lcn2). 
Structurally, human NGAL contains a 20-amino acid signal peptide at the N-terminal end of 
the protein followed by the "lipocalin" domain. This domain which is responsible for 
binding of lipocalins to their ligands, is structurally comprised of an eight stranded ǃ barrel 
with its loops running in an antiparallel direction. A comparison of the amino acid sequence 
between NGAL homologues in different species reveals that human NGAL is highly similar 
to the homologue present in chimpanzees (98% identity) but shows much less identity to the 
mouse and rat homologues (62% and 63% identity respectively). Despite the limited identity 
of their amino acid sequences, the mouse and human homologue are remarkably similar in 
their domain architecture (Figure 2) and three-dimensional structure. This feature, i.e. 
marked structural identity in the absence of significant sequence identity is a common 
feature of the lipocalin-family of proteins and underlies the conserved function of the 
lipocalin domain. Studies carried out on mouse Ngal (also called mLcn2) have revealed that 
it can bind hydrophobic ligands like retinol, cholesterol oleate and oleic acid (Chu et al., 
1998). NMR (nuclear magnetic resonance) studies have revealed that the NGAL molecule 
contains eight antiparallel ǃ strands that form a barrel shaped structure (Coles et al., 1999). 
Three ǃ bulges present in this barrel (one formed by the 1st and two by the 6th ǃ strand) 
have been suggested to contribute to the ligand binding site of NGAL. Hydrophobic 
residues (Tryptophan, Valine and Phenylalanine) present at the base of this barrel-like 
structure have been shown to be involved in direct binding to the ligand. A patch of 
positively charged amino acid residues (Lysine and Arginine) present near the mouth of the 
barrel and projecting into the open end of the molecule has also been suggested to be also 
important in binding to ligands. Further, a negatively charged "pit" present at the base of the 
barrel formed by the amino acids Aspartate and Glutamate and a nearby unpaired Cysteine 
residue have been suggested to be crucial for binding of NGAL to the gelatinase MMP-9. 
Based on whether NGAL is free or bound to a ligand, it is termed as "apo" or "holo" NGAL 
respectively. The conformational change between these two forms of the protein is affected 
by a conformation change occurring at the open end of the NGAL protein.  
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Fig. 2. Domain architecture of human NGAL and its homologues. Human NGAL and its 
homologues are characterized by a high degree of similarity in their domain architecture. 
All NGAL homologues (with the exception of the horse and wild hog) contain an N-
terminal signal peptide which is cleaved prior to secretion of the protein. This is followed by 
the lipocalin domain (IPR000566 Lipocln_cytosolic_FA-bd) which makes up most of the 
length of the protein. This domain which has the consensus sequence [DENG] - {A} - 
[DENQGSTARK] - x(0,2) - [DENQARK] - [LIVFY] - {CP} - G - {C} - W - [FYWLRH] - {D} - 
[LIVMTA] is characteristic of proteins belonging to the lipocalin family. Structurally, the 
lipocalin domain is an eight stranded antiparallel beta barrel enclosing a ligand binding site 
which can bind to small hydrophobic molecules (e.g. steroids, retinoids, bilins and lipids). 
The rabbit and horse NGAL proteins also contain a second domain called the "lipocalin-2" 
domain (Accession number: IPR013208 Lipocalin_2). This domain is present in a small 
number of proteins (calycin, apolipoprotein D and Lipocalin 2) and is believed to be 
involved in the transport of hydrophobic ligands (Source: 
http://www.ebi.ac.uk/interpro/). 
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Recent data on the ligand binding pocket of NGAL has revealed that it is significantly larger 
and more polar than a similar pocket in other lipocalin proteins (Goetz et al., 2000). This has 
led to the speculation that NGAL may bind to large, macromolecular and relatively less 
hydrophobic ligands including mammalian proteins. However, the identity of one or more 
of these mammalian ligands for NGAL remains to be elucidated. However, NGAL has been 
shown to bind to bacterial proteins. Specifically, it binds to iron-chelating proteins released 
by both gram negative bacteria (i.e. enterobacteria) and mycobacteria (e.g. Mycobacterium 
tuberculosis) (Nairz et al., 2009; Holmes et al., 2005). These proteins, termed as enterochelin 
and carboxymycobactin (CMB) respectively have been shown to bind to the ligand binding 
cavity of NGAL. The latter (i.e. CMBs) however, forms a better fit into the ligand binding 
pocket of NGAL. This has been in part attributed to the larger number of hydrophobic 
residues in CMBs which permits the formation of a larger number of hydrogen bonds and 
Van Der Walls interactions with the ligand binding cavity of NGAL.  
3. Expression of NGAL in normal tissues 
Although first discovered as a component of the late granules of neutrophils, NGAL is also 
strongly expressed in several normal adult human tissues including the non-neoplastic 
breast ducts, kidney, liver, lungs, trachea, small intestine, bone marrow, thymus, prostate, 
adipose tissue and macrophages. A weak to no expression of NGAL is observed in the 
normal pancreas, endometrial glands, and the thymus and peripheral blood leucocytes. 
NGAL is however completely absent from the normal brain, heart, skeletal muscle, spleen, 
testes, ovary and colon (Le, V et al., 1997; Seth et al., 2002; Moreno-Navarrete et al., 2010; 
Cowland et al., 2003; Furutani et al., 1998; Cowland and Borregaard, 1997).  
Limited studies done in human fetal tissues reveal that NGAL is expressed in trophoblast 
cells of the placenta, cartilage forming cells (chondrocytes) and in the epithelial cells present 
in the developing lung and small intestine. NGAL expression has also been reported in the 
epidermis of the fetal skin beginning around the 20th week of gestation. With increasing age 
of the fetus, the expression spreads to the lower layers of the skin and becomes 
progressively concentrated around the hair follicles (Mallbris et al., 2002).  
4. Altered expression of NGAL in benign and malignant diseases 
4.1 Inflammatory diseases 
The expression of NGAL is altered in several benign disease conditions including 
inflammatory and metabolic disorders. Inflammatory conditions associated with an increase 
in NGAL expression include pancreatitis, meningitis, myocarditis, psoriasis and 
periodontitis.  
Acute pancreatitis (AP) is a reversible, acute inflammation of the pancreas that affects nearly 
210,000 patients every year in the United States alone (Banks and Freeman, 2006). While 
nearly 85% of these patients have a mild form of the illness (termed as mild acute 
pancreatitis or MAP) and make an uneventful recovery, about 15%-20% of them develop 
features of severe acute pancreatitis (SAP) (Carroll et al., 2007). SAP is associated with 
significant morbidity and mortality primarily owing to multi-organ failure (MOF, usually in 
the first week following onset of disease) and infected pancreatic necrosis (2 weeks or later 
after onset of disease). We have reported that compared to healthy individuals and those 
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with MAP, plasma NGAL levels are significantly elevated (nearly 15-fold) within 48 hours 
(of onset of symptoms) in patients with SAP (Chakraborty et al., 2010). The NGAL levels 
showed a tendency to decline when measured in blood samples collected at later time points 
(i.e. 72 hrs, 96 hrs and 120 hrs). To get a better idea of the time course of the rise in NGAL 
levels in the blood, we induced either mild or severe acute pancreatitis in mice and followed 
the change in plasma Ngal levels over time. We found that Ngal levels in mice rose early 
(within 6 hours following induction of AP) and remained elevated in those with SAP while 
trending down to levels in control mice (no pancreatitis) and in those with MAP.  
Meningitis, particularly that caused by gram negative bacteria can cause a systemic 
inflammatory response syndrome (SIRS) associated with sepsis and significant mortality. A 
key mediator of this inflammatory response is lipopolysaccharide (LPS), a structural 
biomolecule present in the outer wall of gram negative bacteria. LPS is a potent stimulator 
of the immune response and a central player in septic shock in patients with gram negative 
bacterial infections. Ngal mRNA levels were found to be significantly induced in the 
choroid plexus (a structure in the ventricles of the brain that produces cerebrospinal fluid) 
within 12 hours following intraperitoneal injection of LPS while the levels of circulating 
Ngal (in the cerebrospinal fluid) was strongly induced within 6 hours after injection of LPS 
(Marques et al., 2008).  
A significant increase in the level of circulating Ngal was also noted in rats induced to 
develop features of autoimmune myocarditis by injection of purified porcine myosin (Ding 
et al., 2010). However, compared to the acute inflammations described earlier, the elevation 
in Ngal in the rats was significantly delayed, being first evident 9 days following 
immunization with the foreign protein. A significant increase in NGAL mRNA levels has 
also been reported in the heart tissues from patients with myocarditis (Ding et al., 2010).  
Psoriasis, a chronic inflammatory disease of the skin is characterized by the formation of 
plaques covered by variable amount of scales. NGAL mRNA levels were shown to be 
significantly upregulated (nearly 10-fold) in the psoriatic lesions (Nomura et al., 2003; 
Mallbris et al., 2002). Further, NGAL levels were also upregulated in lesions that like 
psoriasis, exhibited a dysregulation in the process of keratinocyte differentiation (termed as 
parakeratosis). These diseases include pityriasis rubra pilaris, porokeratosis and chronic (not 
acute) eczema. Significantly, NGAL expression (from the affected areas of skin) disappeared 
once the psoriatic lesions had healed with treatment, suggesting that NGAL may play a role 
in the pathogenesis of diseases with dysregulated epidermal differentiation. 
NGAL levels were significantly elevated in gum (i.e. alveolar mucosa) tissue from patients 
affected with localized juvenile periodontitis (LJP), a chronic inflammatory disease of the 
gums affecting young adults and associated with severe destruction of both soft tissues and 
bone (Van Dyke et al., 1985). In addition to bacterial infections, NGAL, particularly 
circulating levels are significantly altered in certain viral infections. For instance, circulating 
NGAL levels were significantly lower in patients infected with the human immune 
deficiency virus (HIV) who had not received any therapy (i.e. treatment naïve) compared to 
non-HIV controls. Significantly, treatment of these patients with the highly active anti-
retroviral therapy (HAART) was associated with a progressive increase in circulating NGAL 
levels (Landro et al., 2008). In vitro studies using neutrophils isolated from the three groups 
of patient revealed that in healthy and HAART-treated HIV positive patients, the 
neutrophils released NGAL normally into the culture medium. However, in untreated HIV 
positive patients, this process was defective suggesting that the release of NGAL from 
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neutrophils is inhibited by HIV infection and can be restored following therapy. What 
proteins of the virus mediate this inhibition, and if there is a prognostic significance of the 
restoration of NGAL levels following HAART therapy remain unanswered questions. 
4.2 Metabolic diseases 
Metabolic diseases associated with a dysregulation in NGAL expression include obesity, 
pre-eclampsia and kidney disease.  
Obesity, defined as a body mass index (BMI) of ≥30kg/m2 is now recognized to be 
associated with low grade chronic inflammation and insulin resistance (Pi-Sunyer, 2002). 
Studies have shown that NGAL levels are significantly elevated in the adipose tissues of 
both overweight mice and obese human subjects (Wang et al., 2007). Studies in healthy 
human subjects have revealed that insulin can significantly increase the level of circulating 
NGAL in the blood (Tan et al., 2009). Similar results have emerged from studies in pregnant 
women with gestational diabetes who had significantly higher levels of circulating NGAL 
than those without this complication of pregnancy (D'Anna et al., 2009a).  
Another pregnancy associated complication associated with a rise in circulating NGAL 
levels is pre-eclampsia. This condition, characterized by the development of hypertension in 
or after the 20th week of pregnancy is associated with significant maternal and fetal 
complications. The elevated levels of NGAL in pre-eclampsia were positively correlated 
with both systolic and diastolic blood pressure and presence of proteinuria but showed a 
significant negative correlation with maternal age, pre-pregnancy BMI and weight (D'Anna 
et al., 2008; D'Anna et al., 2009b). Other conditions where NGAL levels are significantly 
elevated include atherosclerosis (Anwaar et al., 1998; Elneihoum et al., 1997; te Boekhorst et 
al., 2011) and hepatitis (Bu et al., 2006). Both hyperlipidemia and chronic alcohol ingestion 
are associated with significant metabolic perturbations and the aforementioned correlative 
studies suggest that NGAL has a role to play in the pathogenesis of these diseases. With the 
development of animal models to study the function of NGAL (discussed later), it is 
expected that the mechanisms by which NGAL modulates metabolic pathways in health 
and disease will become better delineated in the near future. 
The kidney is essential for our survival as it performs the crucial function of maintaining the 
fluid and mineral balance in our body. This in turn maintains the osmolarity of inter and 
intracellular fluids crucial for cellular metabolism. Both acute and chronic damage to the 
kidneys causes metabolic perturbations associated with a significant increase in the 
expression of NGAL.  
Chronic kidney disease (CKD) is a disease characterized by a progressive decline in renal 
function and associated with significant morbidity. Studies in a mouse model that mimics 
the pathophysiology of CKD in humans revealed that NGAL is the most highly upregulated 
gene in the kidneys of mice with severe CKD (Viau et al., 2010). It appears that the damaged 
kidneys synthesize a significantly higher amount of NGAL than usual, particularly in the 
proximal convoluted tubules (PCT) and the ascending limb of the loop of Henle. NGAL 
being a secreted protein is then released into the ultrafiltrate and subsequently excreted in 
urine. The level of Ngal expression in the diseased kidneys correlated positively with the 
severity of renal lesions (in mice) suggesting that Ngal may promote renal damage in CKD 
(Viau et al., 2010). A similar observation was also noted in an animal model of autosomal 
polycystic kidney disease (ADPKD), another cause of CKD in humans (Lau et al., 2000).  
NGAL levels are elevated in acute kidney injury (AKI) resulting from a wide variety of 
insults to the kidney ranging from ischemia to toxins. This rise occurs early and depends on 
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both the cause and the extent of renal damage. For instance, following ischemic injury, 
NGAL levels in the kidney tissue rises by nearly 10-fold within only 3 hours (Mishra et al., 
2003). Further, the rise appears to be sustained, being evident for several days following the 
initial insult. This pattern, an early rise and persistence, makes NGAL a highly sensitive 
marker of early AKI. Like in CKD, the kidney is the major source of NGAL release in AKI. 
However, other sources of NGAL that have been suggested include organs that synthesize 
and release mediators of an acute inflammatory response (e.g. the liver) and immune cells 
that contain NGAL in their granules (neutrophils and macrophages) (Hvidberg et al., 2005). 
4.3 Malignant diseases 
The expression of NGAL is significantly increased in several solid and hematological tumors 
and been shown to correlate with both tumor characteristics and disease outcome. Solid tumors 
that express high levels of NGAL arise in a variety of organs including the digestive (e.g. 
esophagus, stomach, liver, bile ducts and pancreas), respiratory (lungs), endocrine (thyroid 
gland and ovaries), reproductive (breast and endometrium) organs and even in the skin.  
Pancreatic cancer (PC) is the most lethal of all malignant solid tumors in humans 
(Chakraborty et al., 2011). Several groups including ours have now shown that while NGAL 
is either completely absent or weakly expressed in the normal pancreatic ducts, a strong 
expression of NGAL is seen in the malignant cells (Moniaux et al., 2008; Furutani et al., 1998; 
Tong et al., 2008; Tong et al., 2011). We also observed that the expression of NGAL first 
appears in pre-malignant lesions (termed as Pancreatic intraepithelial neoplasia or PanINs), 
with a progressive increase from low to high grade dysplasia. In invasive pancreatic cancer, 
NGAL expression was significantly higher in well-differentiated PC while poorly 
differentiated cancer cells showed no expression of the protein (Moniaux et al., 2008). 
Functional studies to investigate the role of NGAL in PC (discussed later) suggest that it 
plays a role in the progression of this deadly malignancy. Further, quantitative 
measurement of NGAL levels in plasma revealed that there was a significant increase in the 
levels of NGAL in the plasma compared to healthy individuals. These results suggest that 
NGAL might be potentially useful as a novel biomarker for the diagnosis of PC. Similar to 
PC, NGAL was weakly expressed by the normal liver cells but strongly expressed in 
hepatocellular carcinoma (Lee et al., 2011). In gastric cancer however, NGAL expression 
remains controversial with two groups reporting opposing results- one reporting 
overexpression and the other a significant downregulation of NGAL in pre-malignant and 
malignant gastric tissues (Alpizar et al., 2009; Wang et al., 2010).  
Ngal, the mouse homologue of human NGAL was strongly upregulated in mice that 
overexpress Insulin like growth factor (IGF-2), a major growth promoting hormone that acts 
during in utero development. These mice developed lung tumors spontaneously which 
showed a significant upregulation of Ngal mRNA.  
Among the endocrine tumors, papillary, follicular and anaplastic thyroid cancers all express 
NGAL (Iannetti et al., 2008). Notably, the expression of NGAL increases with the loss of 
tumor differentiation. While NGAL is not detected in the normal ovarian follicles and 
weakly expressed in benign ovarian tumors, a strong expression of NGAL is noted in 
borderline and grade 1 (well differentiated) malignant ovarian tumors (Lim et al., 2007). 
Interestingly, its expression decreased in grade 2 (moderately differentiated) and 3 (poorly 
differentiated) ovarian cancer (Cho and Kim, 2009).  
Of the malignancies arising from reproductive organs, ductal carcinoma of the breast and 
endometrial cancer express high levels of NGAL (Miyamoto et al., 2011; Bauer et al., 2008). 
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NGAL appears to promote the progression of breast cancer, being higher in actively 
proliferating cells, in lymph node metastasis and cells positive for the human epidermal 
growth factor receptor-2 (HER-2/ErbB2). Studies in cell lines suggest that NGAL expression 
in breast cancer may be regulated by HER-2 (Stoesz and Gould, 1995). In fact, another name 
for the Ngal protein in rats is Neu-related lipocalin (Neu being the other name for HER-2).  
Microarray analysis using microdissected normal and malignant endometrial glands 
revealed that NGAL was strongly upregulated in the malignant endometrial glands . 
Immunohistochemical analysis of formalin fixed and paraffin embedded tissues also 
revealed that while the normal endometrium showed a weak expression of NGAL, a strong 
expression was noted in the areas of endometrial carcinoma (Miyamoto et al., 2011).  
NGAL is also secreted by the malignant cells in hematological malignancies. Studies done 
on the murine homolog of NGAL (24p3/Ngal) suggest that in leukemias, particularly those 
where the cells expresses BCR-ABL, 24p3/Ngal is strongly expressed by the malignant cells 
(Devireddy et al., 2005; Arlinghaus and Leng, 2008). BCR-ABL is a fusion protein that is 
found in association with certain leukemias, chiefly chronic myelogenous leukemia (CML) 
and to a lesser extent in acute lymphoblastic leukemia (ALL) and rarely in acute 
myelogenous leukemia (AML). This fusion results from a reciprocal translocation event 
occurring between the long arms of chromosomes 9 and 22.  The resultant protein encodes 
for a protein kinase, specifically a tyrosine kinase that is constitutively active (i.e. does not 
require any external activation signal). As shown in Figure 3, normal hematopoietic cells 
(but not the BCR-ABL positive leukemia cells) in mice express the receptor for Ngal (called 
NgalR or 24p3R). The leukemia cells release large quantities of 24p3/Ngal into the 
bloodstream which acts via its receptor to induce cell death in the normal hematopoietic 
cells. Since the leukemic cells do not express the receptor, they remain unaffected. This 
 
 
Fig. 3. Role of NGAL in hematopoietic malignancies: 24p3, the mouse homologue of human 
NGAL is secreted from BCR-ABL expressing mouse leukemic blast cells, a process that can be 
blocked using Imatinib, a specific inhibitor of the BCR-ABL tyrosine kinase activity. The 24p3 
in the conditioned medium induces apoptosis in normal hematopoietic cells (express the 24p3 
receptor or 24p3R) but not in the BCR-ABL+ leukemic cells that are devoid of 24p3R. 
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mechanism has been suggested to be responsible for the spread of leukemia cells through 
the healthy bone marrow (Hu et al., 2009; Leng et al., 2008; Lin et al., 2005). Further, studies in 
mice also suggest that while 24p3/Ngal is required for the establishment of BCR-ABL+ 
leukemia cells in the spleen and bone marrow, it is the BCR-ABL but not Ngal was the gene 
ultimately driving the progression of the disease. Studies in CML patients have confirmed 
the findings in mice. Both NGAL mRNA and plasma levels are significantly elevated in 
patients with CML (Leng et al., 2008; Villalva et al., 2008). Further, patients who responded 
to treatment with Imatinib (a specific inhibitor of BCR-ABL tyrosine kinase) showed a 
significant decrease in NGAL mRNA (but not in plasma NGAL levels).  (Owen et al., 2008) 
5. Functions of NGAL 
An important function of NGAL under physiological conditions is to act as bacteriostatic 
agent, thus protecting the body against both gram negative bacteria and mycobacterial 
infection. It mediates this function by binding with strong affinity to bacterial iron binding 
proteins called siderophores. Iron, particularly ferrous form is required by bacteria for their 
growth. However, the extremely low levels of free iron in the body make it an essential 
nutrient required by bacterial cells. To circumvent this requirement for iron, bacteria have 
evolved a mechanism involving the expression of proteins (termed siderophores) that bind 
to free iron (present in the intestinal fluid and inside macrophages) particularly in its ferric 
form. NGAL has a strong affinity to bind to siderophores, both when free and when laden 
with iron. Upon binding to these proteins, the NGAL siderophore complex is taken up by 
cells expressing the cognate receptor for NGAL and thus these iron laden proteins are 
sequestered away. In this way, by depriving bacteria of an essential nutrient, NGAL inhibits 
their proliferation (Nairz et al., 2009; Holmes et al., 2005).  
The recent discovery that catechols, a family of plant derived metabolites present in our diet, 
can bind NGAL has opened new possibilities for the functional role of human NGAL in 
health and disease. Interestingly, while catechols itself bound weakly to NGAL, their 
binding was significantly enhanced in the presence of iron, specifically ferric iron. More 
detailed studies have revealed that three catechol molecules form a complex (a 
triscatecholate complex) with iron acting as a stabilizing agent through formation of pi 
interactions and electrostatic interactions with the catechol molecules. This ferric-
triscatecholate complex then binds to the ligand binding cavity (calyx) of NGAL. In mice, it 
has been observed that this complex of Ngal and iron-catechol is filtered through the 
kidneys before being re-absorbed in the proximal convoluted tubules through specific Ngal 
receptors (Bao et al., 2010; Backhed et al., 2005). However, the function of these complexes 
alone and in combination with Ngal still remains to be elucidated.   
Other functions attributed to Ngal include acting as a chemoattractant for neutrophils and 
as an inhibitor of cellular oxidative stress. The former function is based on observations that 
mice in which the Ngal gene is knocked out show a significant decrease in the number of 
neutrophils infiltrating transplanted heart tissue (compared to wild type mice with both 
copies of the gene intact). This suggests that neutrophils, the primary effectors of acute 
inflammatory response in the body, require NGAL to home in to the target organs (in this 
case the transplanted heart). The latter role is suggested from observations made in both 
Chinese hamster ovary (CHO) and human embryonic kidney (HEK) cells that an aberrant 
expression of 24p3/Ngal leads to a significant upregulation in the expression of the 
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antioxidant enzymes superoxide dismutase (SOD) and heme oxygenase (HO) (Bahmani et 
al., 2010; Roudkenar et al., 2007; Roudkenar et al., 2008c; Roudkenar et al., 2008a; Roudkenar 
et al., 2008b).  
NGAL also appears to play a role in wound healing. In a study of patients with chronic 
venous ulcers (CVUs), an analysis of the exudate from the wounds of those with either 
healing (H) or non-healing (NH) CVUs revealed that the former (H-CVU) group had a 
significant decline the level of exudate-NGAL levels compared to the latter (NH-CVU) 
group of patients (Pukstad et al., 2010). 
NGAL also appears to modulate proliferation and synthesis of cartilage by murine 
chondrocytes and promotes proliferation of renal tubular epithelial cells (Owen et al., 2008). 
Apart from healthy cells, NGAL also modulates proliferation and survival of certain types 
of malignant cells (thyroid cancer and hepatocellular carcinoma). In the former type of 
cancer cells, NGAL appears to promote proliferation and survival, while it had the opposite 
effect in hepatocellular carcinoma cells (Iannetti et al., 2008; Lee et al., 2011). In other types of 
cancer cells (e.g. pancreatic, breast and colon cancer) however, NGAL does not seem to have 
any effect on proliferation. Instead, it significantly inhibits the ability of these cancer cells to 
invade and metastasize (Tong et al., 2008; Lee et al., 2006). Two possible mechanisms have 
been suggested to explain this anti-invasive effect of NGAL. One mechanism involves 
inhibition of the non-receptor tyrosine kinase FAK (focal adhesion kinase). FAK interacts 
with Src (another non-receptor tyrosine kinase) and provides a scaffold for activation of the 
Ras-MAPK (Mitogen activated protein kinase pathway), a key mediator of metastasis in 
cancer cells. NGAL, by inhibiting FAK would in turn inhibit the Ras-MAPK pathway and 
thus block both invasion and metastasis of cancer cells. A second mechanism, based on 
studies by our group, suggests that E-cadherin when ectopically expressed can increase 
expression of NGAL (Tong et al., 2011). E-cadherin is a calcium dependent cell adhesion 
molecule that is expressed in and promotes epithelial cells to adhere to one another (thus 
preventing metastasis).  Further, studies by us in human pancreatic cancer cells also suggest 
that NGAL inhibits angiogenesis (formation of blood vessels) (Tong et al., 2008). A clue to 
the underlying mechanism comes from observations that conditioned media from 
pancreatic cells in which endogenous NGAL had been silenced (using short hairpin RNAs) 
significantly decrease formation of capillary like structures by human vascular endothelial 
(HUVEC) cells in vitro. This is associated with a significant decrease in the release of 
vascular endothelial growth factor (VEGF), a key promoter of angiogenesis from the NGAL 
silenced cells. 
Knockout of both copies of the murine Ngal homologue (i.e. Ngal-/- mice) did not result in 
any phenotypic abnormalities in the knockout mice compared to their wild type littermates. 
However, the Ngal knockout mice were significantly more sensitive to infection with gram 
negative bacteria, exhibiting a nearly 1000-fold greater bacteremia (upon infection with 
Escherichia coli, a gram negative enteric pathogen) compared to their wild type littermates. 
Further investigation revealed that there was no difference in the absolute number of 
different leukocyte subpopulations between the wild type (Ngal+/+) and knockout mice 
(Ngal-/-) (Flo et al., 2004). As discussed earlier, Ngal is crucial to prevent growth of bacteria, 
particularly within the macrophages and also for homing of neutrophils to sites of acute 
inflammation (including bacterial infection). Both these mechanisms would be severely 
affected in the Ngal knockout mice, thus contributing to the enhanced bacteremia and 
resulting mortality. These observations suggest that lack of Ngal produces a qualitative 
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rather than a quantitative defect in the immune system that in turn leads to an increased 
susceptibility to gram negative sepsis. 
6. Regulation of NGAL expression 
Given the observation that NGAL is differentially expressed in a wide array of benign and 
malignant diseases, it is extremely important to investigate the mechanisms that regulate its 
expression. Most studies have focused on the regulation of transcription of its mRNA. 
Several cytokines, hormones, vitamins, minerals, synthetic drugs and growth factors have 
been shown to influence the expression of NGAL (Table 2). Each of these probably acts in a 
context dependent manner to influence the expression of this glycoprotein.  
NF-κB , a transcription factor and regulator of several key pathways in the cell has emerged 
as a front runner in the regulation of NGAL gene expression.  The NF-κB  family comprises 
five transcription factors (p50, p52, p65 (or RelA) and c-Rel and RelB). These proteins are 
related to one another by the presence of the Rel homology domain (RHD), present in the N-
terminal region of each member of this family. The C-terminal region contains either a 
transcription activation domain (TAD, in case of RelA, c-Rel and RelB) or a transcription 
repression domain (TRD in case of p50 and p52). These proteins form homo or heterodimers 
with each other through the RHD domain and then bind to short (9-10 bases long) sequence 
in the promoter or enhancer regions of target genes (termed as kB response elements). RelA, 
c-Rel and RelB activate gene expression (owing to presence of the TAD) while p50 and p52 
inhibit gene expression (through the TRD) unless they associate with another member that 
has a TAD in its C-terminus. NGAL too has κB elements in its promoter region and has been 
shown to be positively regulated by agents that induce NF-κB  (like insulin, IL-1ǃ and 
TLRs). Another pathway that has been shown to promote NGAL expression is the JNK (c-
jun N-terminal kinase) MAPK pathway. Cytokines like IL-1 and IL-17 can both activate the 
JNK pathway. A cross talk between the JNK and NF-κB  has been suggested to act together 
to upregulate NGAL expression (Florin et al., 2004; Yang et al., 2008; Park et al., 2005). 
Dexamethasone, a synthetic corticosteroid induces NGAL mRNA expression acting through 
the glucocorticoid receptor (GRs) and glucocorticoid response elements (GREs) present in 
the promoter region of NGAL (Garay-Rojas et al., 1996).  
The epidermal growth factor receptor (EGFR) when activated initiates signaling events that 
promote cell proliferation, survival and enhance migration and invasiveness of a variety of 
cancer cells. We have reported that EGF treatment decreases the expression of NGAL 
mRNA. This was associated with a significant downregulation of the epithelial marker E-
cadherin. Mechanistically, EGF mediated downregulation of NGAL expression occurs by 
inhibition of the NF-κB  pathway (Tong et al., 2011). However, the role of EGF in regulating 
NGAL appears to be dependent on the cell type. For instance, treatment of mouse renal 
tubular epithelial cells with EGF led to a significant upregulation of Ngal expression. The 
mechanism of upregulation of Ngal by EGF (in mice renal cells) appears not to be through 
the NF-κB pathway but rather through stabilization of the transcription factor HIF-1ǂ 
(hypoxia inducible factor-1 ǂ).  
Epigenetic mechanisms have been shown to be central to the process of de novo induction or 
repression of genes. Treatment of endometrial cancer cells that express a low level of NGAL 
with a demethylating agent 5-aza cytidine led to a significant upregulation of NGAL 
mRNA. However, the same agent had no effect on cells that had a high basal level of NGAL 
(Miyamoto et al., 2011). This suggests that methylation may be a mechanism to differentially 
turn on or off the expression of NGAL in disease states including cancer.   
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Factors 
Comments Effect on NGAL 
expression 
Cytokines   
GM-CSF 
Granulocyte Monocyte colony stimulating 
factor 
↑ 
IL-1ǂ Interleukin 1 alpha ↑ 
IL-1ǃ Interleukin 1 beta ↑ 
IL-6 Interleukin 6 ņ 
IL-17 Interleukin 17 ↑ 
IL-22 Interleukin 22 ↑ 
TGF-ǂ Transforming growth factor alpha ↑ 
TNF-ǂ Tumor necrosis factor alpha ņ/Ņ a 
bFGF Basic fibroblast growth factor ņ 
Growth factors   
IGF-1 Insulin like growth factor-1 ↑ 
EGF Epidermal growth factor Ņ/↑ a 
Synthetic drugs  ↑ 
Dexamethasone Synthetic corticosteroid ↑ 
Deferoxamine Iron-chelator ↑ 
Diethylstilbestrol Synthetic nonsteroidal estrogen ↑ 
5-aza cytidine Demethylating agent ↑ 
Hormones   
Insulin  ↑ 
Estrogen  Ņ/↑ a 
Progesterone  ņ 
Bacterial components   
LPS Lipopolysaccharide (TLR-4 ligand) ↑ 
Lipotechoic acid Gram +ve bacterial cell wall component ↑ 
Peptidoglycan Gram +ve bacterial cell wall component ↑ 
Others   
HIV-tat HIV virus tat protein ↑ 
Pam3CSK4 TLR-1/2 ligand ↑ 
Flagellin TLR-5 ligand ↑ 
pIC Polyinosinic polycytidylic acid (TLR-3 ligand) ↑ 
CpG 
Unmethylated CpG oligonucleotides  
(TLR-9 ligand) 
↑ 
Calcium Promotes cell differentiation  ↑ 
Footnote 1 ↑ Indicates upregulation, Ņ indicates downregulation and ņ indicates no effect on NGAL 
expression. a The same factor can have opposite effects on NGAL expression in a context dependent 
manner. HIV (Human Immune deficiency virus), TLR (Toll like receptor). 
Table 2. Summary of factors regulating NGAL expression 
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These reports taken together suggest that multiple stimuli, acting through a relatively small 
number of pathways regulate the expression of NGAL. However, many of these studies 
have been done in vitro and need to be examined in vivo particularly using knockout mouse 
models. Nonetheless, they shed important light on the complex regulation of this protein 
and will be important in future attempts to modulate its expression for therapeutic 
purposes.  
7. Role of NGAL as a diagnostic and prognostic marker 
The differential expression of NGAL in disease states has been utilized as a rationale to 
investigate the potential of NGAL as a biomarker in the diagnosis of these diseases. Among 
benign diseases, acute kidney injury (AKI) represents the disease where this secreted protein 
has been most extensively studied for its diagnostic performance. In one study, urine NGAL 
levels rose significantly within as early as 6 hours following elective cardiac surgery in patients 
admitted to the intensive care units (ICU) who met the criteria for AKI, suggesting that it is an 
early marker of renal injury (Koyner et al., 2010). Further, corrected urine NGAL levels 
(corrected for serum creatinine) when measured at the time of the patient's arrival to the ICU 
was a good predictor of severe AKI post-cardiac surgery (Area under the curve or AUC being 
0.88, 95% CI: 0.73-0.99). Another study found that among post-cardiac surgery patients, 
plasma NGAL levels rose upto 24 hours prior to patients meeting the current clinical criteria 
for AKI (i.e. the RIFLE or Risk, Injury, Failure, Loss and End stage renal disease criteria) (Cruz 
et al., 2010). Further, plasma NGAL was a good predictor of the need for renal replacement 
therapy (RRT) during the stay of the patients in the ICU (AUC 0.82, 95% CI 0.70-0.95). NGAL 
is also an early predictor of DGD (delayed graft dysfunction), a type of renal dysfunction in 
kidney transplant recipients that often develops within a week after transplant and is often 
severe enough to require dialysis (Korbely et al., 2011; Shapiro et al., 2010).  
Pre-renal azotemia refers to reversible renal injury which is completely reversible within 24-
72 hours if the cause is removed. Distinguishing pre-renal azotemia from AKI is one of the 
major challenges for nephrologists and critical care physicians today. A comparison of urine 
NGAL levels between patients with pre-renal azotemia and AKI revealed that urine NGAL 
levels were significantly higher in patients with AKI (mean±SEM level being 416+387 μg/g 
of creatinine) compared to those with pre-renal azotemia (mean±SEM being 30+92 μg/g 
creatinine) (Nickolas et al., 2008). The results were validated in another independent cohort 
of 107 patients, 32 of whom had pre-renal azotemia (Singer et al., 2011).   
Diagnosis of AKI in children presents a special challenge. Owing to the incomplete 
development of their nephrons, they have higher baseline levels of creatinine than adults. 
Hence, serum creatinine may not be an appropriate marker to detect AKI in these patients. 
A comparison of NGAL and creatinine in pediatric patients (both neonates and older 
patients) revealed that urine NGAL levels were elevated within 2 hours following 
cardiopulmonary bypass (CPB) surgery and remained elevated for even upto 48 hours. 
Significantly, urine NGAL >185 ng/ml or a plasma NGAL >95 ng/ml was 100% sensitive 
(88% for plasma) and 93% specific (both urine and plasma) in identifying AKI in neonatal 
patients. The corresponding cut-off for older children was >45ng/ml (urine) or >48ng/ml 
(plasma). The corresponding sensitivity and specificity were 85% (90% for plasma) and 86% 
(88% for plasma) respectively (Krawczeski et al., 2011). 
Elevation in NGAL, particularly in combination with an elevation in the levels of IL-1 
receptor and protein C was the best predictor of the risk of developing severe sepsis among 
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a panel of nine potential markers in a cohort of 506 patients admitted with systemic 
inflammatory response syndrome (SIRS) (AUC 0.75, 95% CI 0.72-0.78 vs. those who did not 
develop severe sepsis). This panel of three markers was also fairly accurate in predicting 
both septic shock (AUC 0.77) and death (AUC 0.79) within 24 hours of hospital admission in 
critically ill patients (Endre et al., 2011).  
In addition to its role as a diagnostic marker, NGAL has also emerged as an important 
prognostic indicator in several diseases. Studies in obese type-2 diabetics revealed that 
serum NGAL levels were negatively correlated with the levels of total cholesterol, an 
important determinant of coronary artery disease (CAD). Further, the level of serum NGAL 
was an independent predictor of insulin resistance and hyperglycemia in these patients. In 
patients with acute decompensated heart failure (ADHF), serum NGAL levels (at 
admission) were significantly higher in those patients who had worsening of renal function 
(WRF) compared to those whose renal function was intact. At a cut-off of ≥140 ng/ml, 
serum NGAL was 86% sensitive and 54% specific in predicting the development of WRF in 
these patients (Chertow et al., 1998).  
NGAL has been widely investigated as a prognostic indicator in AKI from various causes. In 
patients undergoing cardiovascular surgery, AKI is always a potential complication 
predominantly due to ischemia during the procedure. Urine NGAL levels have been shown 
to be fairly accurate (AUC 0.59-0.65) in early identification (within 3 hours) of AKI following 
CPB surgery (Shapiro et al., 2009). We have demonstrated that an elevated plasma NGAL 
level among patients with SAP is associated with a significantly poor outcome (i.e. increased 
risk of death). This effect appears to be specific to SAP as no such correlation was observed 
in MAP patients. Further, in a small study, NGAL appeared to perform equal or better than 
other established clinical prognostic indicators in SAP (i.e. serum creatinine, Ranson’s score 
and the APACHE-II score) (Chakraborty et al., 2010). 
As techniques continue to evolve, it is expected that assays for NGAL will become 
increasingly sensitive. One study comparing ELISA (enzyme linked immunosorbent assay) 
with RIA (radioimmunoassay) found that the latter was between 5-10 fold more sensitive 
than ELISA in detecting a rise in NGAL among patients undergoing cardiac surgery, with 
the sensitivity being the highest in the first 2 hours (Aghel et al., 2010). 
NGAL has also emerged as a potential biomarker in several epithelial malignancies. In 
gastric cancer patients, serum NGAL could distinguish patients with cancer from non-
cancer patients with an AUC of 0.93 (Wang et al., 2010). NGAL was better than either CA19-
9 or CEA (carcinoembryonic antigen) in identifying early gastric cancer (i.e. Stage 1 and 2) 
patients suggesting that it could be a potential biomarker for early stage gastric cancer. 
NGAL was also fairly accurate in discriminating between benign and malignant biliary 
obstruction (AUC 0.76 with a sensitivity and specificity of 96% and 56%) (Klapper et al., 
2008). In ovarian cancer however, NGAL was 72% sensitive but only 50% specific in 
distinguishing ovarian cancer from non-cancer patients. In comparison, CA125 was 80% 
sensitive and 79% specific in distinguishing between the two groups (Argani et al., 2001). 
NGAL also appears to correlate with prognosis of cancer patients. For instance, patients 
whose tumors expressed NGAL had a significantly shorter survival (both disease specific 
and disease free) compared to those with NGAL non-expressing tumors (12.2 years in 
NGAL expressing vs. 17.1 years in NGAL non-expressing tumors). Multivariate analysis 
revealed that NGAL was an independent predictor of disease free survival (hazard ratio 
1.85). In gastric cancer too, patients whose tumors expressed NGAL had a significantly 
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shorter survival compared to tumors whose tumors did not express any NGAL (35.6 
.months vs. 54.4 months  respectively) (Alpizar et al., 2009). 
8. Conclusions 
The preceding discussion suggests that NGAL, despite its low molecular weight is an 
important protein particularly from the standpoint of protecting against bacterial infections. 
Further, it appears that NGAL has other novel functions in disease states, particularly in 
epithelial malignancies where it can modulate cell proliferation, cell death, invasion and 
metastasis of cancer cells. In other diseases, particularly in renal injury, the role of NGAL 
remains to be elucidated.  
NGAL expression appears to be regulated by a variety of stimuli through mainly the NF-κB 
pathway although epigenetic modifications may be important, particularly in initiating its de 
novo expression during diseases like cancer. NGAL has also emerged as a biomarker with 
immense clinical potential, both in benign and malignant diseases. Further, while limited 
studies exist, it also appears to be capable of predicting the outcome of patients with 
multiple diseases.  
All these features make NGAL an important diagnostic target. An interesting observation is 
that the Ngal knockout mice do not exhibit any obvious defects. However, they are 
extremely sensitive to infection by gram negative bacteria. These results clearly suggest that 
NGAL may be an important protective agent in gram negative bacterial infections. Further 
studies using these mice will be crucial to delineate its role in determining sensitivity to 
other inflammatory and malignant diseases. Taken together, NGAL has emerged as a 
clinically important member of the lipocalin family and holds immense potential for 
diagnostic and therapeutic applications in the future. 
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